Aggribloc 5 mg/100 mL Injection
Aggribloc 5 mg/100 mL Injection Aggribloc contains tirofiban hydrochloride, a short-acting intravenous antiplatelet medicine. It is a glycoprotein IIb/IIIa receptor antagonist that inhibits platelet aggregation and helps prevent the formation or growth of blood clots in the coronary circulation.
The product shown is Aggribloc 5 mg/100 mL, supplied as a single-dose preparation for intravenous infusion only. Abbott India lists Aggribloc under its cardiovascular/cardio-diabetes portfolio.
| Brand | Aggribloc |
| Storage Temperature | Store below 30°C; protect from light |
| Prescription Needed | Yes |
| Composition | Tirofiban Hydrochloride |
| Strength | 5 mg/100 mL |
| Form | infusion solution |
| Pack Size | 100 mL × 1 single-dose vial |
| Packaging | Vial |
| Country of Origin | Made In India |
| Manufacturer | Abbott |
Aggribloc 5 mg/100 mL Injection
Aggribloc 5 mg/100 mL Injection Aggribloc contains tirofiban hydrochloride, a short-acting intravenous antiplatelet medicine. It is a glycoprotein IIb/IIIa receptor antagonist that inhibits platelet aggregation and helps prevent the formation or growth of blood clots in the coronary circulation.
The product shown is Aggribloc 5 mg/100 mL, supplied as a single-dose preparation for intravenous infusion only. Abbott India lists Aggribloc under its cardiovascular/cardio-diabetes portfolio.
